arrow
Back
D

David Lewis

university hospitals plymouth nhs trust

23H-index
113Paper Count
3.1KCitation Count
Published Papers 18
Publication Date
Ibrutinib and rituximab versus immunochemotherapy in patients with previously untreated mantle cell lymphoma (ENRICH): a randomised, open-label, phase 2/3 superiority trial
err2025-10-03
err0
errOAAI
errDavid J Lewis; Mats Jerkeman; Lexy Sorrell; David Wright; Ingrid Glimelius; Christian B Poulsen; Annika Pasanen; Andrew Rawstron; Karin F Wader; Nick Morley; Catherine Burton; Andrew J Davies; Ingemar Lagerlöf; Surita Dalal; Ruth De Tute; Chris McNamara; Nicola Crosbie; Helle Erbs Toldbod; Jeanette Sanders; Victoria Allgar; Sree Aroori; Mark Warner; Claire Scully; Brian Wainman; Jacob Haaber Christensen; Jon Riise; Kristina Sonnevi; Mark J Bishton; Toby A Eyre; Simon Rule
errShare
errSave
Clinical management of bispecific antibody therapy for lymphoma: A British Society for Haematology Good Practice Paper
err2025-09-05
err0
PREAI
errSridhar Chaganti; Vaishali Dulobdas; Matthew R. Wilson; David Tucker; William Townsend; Nilima Parry-Jones; David Lewis; Christopher P. Fox; Wendy Osborne
errShare
errSave
Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial
errBLOOD
IF23.1
err2025-01-10
err3
errOAAI
errBrody, Joshua D.; Jorgensen, Judit; Belada, David; Costello, Regis; Trneny, Marek; Vitolo, Umberto; Lewis, David John; Karimi, Yasmin H.; Sureda, Anna; Andre, Marc; Wahlin, Bjoern E.; Lugtenburg, Pieternella J.; Jiang, Tony; Karagoz, Kubra; Steele, Andrew J.; Abbas, Aqeel; Wang, Liwei; Risum, Malene; Cordoba, Raul
errShare
errSave
Ibrutinib, Venetoclax Plus CD20 Monoclonal Ab Provides Very High MRD Negativity in Previously Untreated MCL Patients, Initial Results of OASIS II, a Randomized Phase 2 Trial
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errLe Gouill, Steven; de Wilde, Virginie; Eyre, Toby A.; Callanan, Mary B.; Damaj, Gandhi; Claudel, Alexis; Chauchet, Adrien; Houot, Roch; Le Calloch, Ronan; Cacheux, Victoria; Andre, Marc; Morschhauser, Franck; Burroni, Barbara; Lewis, David John; Tessoulin, Benoit; Touzart, Aurore
errShare
errSave
Ibrutinib-Rituximab Is Superior to Rituximab-Chemotherapy in Previously Untreated Older Mantle Cell Lymphoma Patients: Results from the International Randomised Controlled Trial, Enrich
errBLOOD
IF23.1
err2024-11-05
err3
PREAI
errLewis, David John; Jerkeman, Mats; Sorrell, Lexy; Wright, David; Glimelius, Ingrid; Pasanen, Annika; Christensen, Jacob Haaber; Wader, Karin Fahl; Davies, Andrew J.; Morley, Nick; Mcnamara, Christopher; Poulsen, Christian Bjorn; Riise, Jon; Sonnevi, Kristina; Lagerloef, Ingemar; Burton, Cathy; Dalal, Surita; Rawstron, Andrew; Tute, Ruth M. de; Allgar, Victoria; Aroori, Sree; Warner, Mark; Wainman, Brian; Scully, Claire; Sanders, Jeanette; Niemann, Carsten Utoft; Toldbod, Helle; Crosbie, Nicola; Bishton, Mark J.; Eyre, Toby A.; Rule, Simon
errShare
errSave
Glofitamab and Epcoritamab in the Real World: A UK Multicentre Retrospective Analysis of Efficacy, Tolerability and Practical Implications
errBLOOD
IF23.1
err2024-11-05
err1
PREAI
errHaynes, Euan; Ediriwickrema, Kushani; Lawless, Sarah; Joyce, Kevin; Wells, Matthew; Smith, Jeffrey; Linton, Kim; Santarsieri, Anna; Follows, George; Willan, John; Osborn, Robert; Wilson, Matthew; Mckay, Pamela; Baloch, Mahina; Mcculloch, Rory; Gleeson, Mary; Wrench, David; Foldes, David; Kanfer, Edward; Maw, Kyaw Zin; Kuhnl, Andrea; Ahearne, Matthew; Owen, Mary; Norman, Jane; De Silva, Ravindu; Shah, Nimish; Ambrose, Harriet; Fox, Christopher P.; Qasim, Janine; Collins, Graham P.; Vickers, Martha; Tucker, David; Chan, Li Yuan; Lyengar, Sunil; el-Sharkawi, Dima; Auer, Rebecca; Cox, Catherine; Hiew, Hwai Jing; Davies, Andrew J.; Kelsey, Philippa; Lewis, David John; Martin, Abigail; Preston, Gavin; Culligan, Dominic J.; Broom, Angus; Wilson, William; Osborne, Wendy; Townsend, William
errShare
errSave
Epcoritamab in relapsed/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trial
errLEUKEMIA
IF13.4
err2024-09-25
err0
errOAAI
errThieblemont, Catherine; Karimi, Yasmin H.; Ghesquieres, Herve; Cheah, Chan Y.; Clausen, Michael Roost; Cunningham, David; Jurczak, Wojciech; Do, Young Rok; Gasiorowski, Robin; Lewis, David John; Kim, Tae Min; van der Poel, Marjolein; Poon, Michelle Limei; Feldman, Tatyana; Linton, Kim M.; Sureda, Anna; Hutchings, Martin; Dinh, Minh H.; Kilavuz, Nurgul; Soong, David; Mark, Thomas; Sacchi, Mariana; Phillips, Tycel; Lugtenburg, Pieternella J.
errShare
errSave
Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study
err2024-08-01
err8
PREAI
errLinton, Kim M.; Vitolo, Umberto; Jurczak, Wojciech; Lugtenburg, Pieternella J.; Gyan, Emmanuel; Sureda, Anna; Christensen, Jacob Haaber; Hess, Brian; Tilly, Herve; Cordoba, Raul; Lewis, David John; Okada, Craig; Hutchings, Martin; Clausen, Michael Roost; Sancho, Juan-Manuel; Cochrane, Tara; Leppa, Sirpa; Chamuleau, Martine E. D.; Gernhardt, Diana; Altintas, Isil; Liu, Yan; Ahmadi, Tahamtan; Dinh, Minh H.; Hoehn, Daniela; Favaro, Elena; Elliott, Brian; Thieblemont, Catherine; Vose, Julie M.
errShare
errSave
Ibrutinib as fi rst-line therapy for mantle cell lymphoma: a multicenter, real-world UK study
err2024-03-01
err4
errOAAI
errTivey, Ann; Shotton, Rohan; Eyre, Toby A.; Lewis, David; Stanton, Louise; Allchin, Rebecca; Walter, Harriet; Miall, Fiona; Zhao, Rui; Santarsieri, Anna; Mcculloch, Rory; Bishton, Mark; Beech, Amy; Willimott, Victoria; Fowler, Nicole; Bedford, Claudia; Goddard, Jack; Protheroe, Sam; Everden, Angharad; Tucker, David; Wright, Josh; Dukka, Vasavi; Reeve, Miriam; Paneesha, Shankara; Prahladan, Mahesh; Hodson, Andrew; Qureshi, Iman; Koppana, Manasvi; Owen, Mary; Ediriwickrema, Kushani; Marr, Helen; Wilson, Jamie; Lambert, Jonathan; Wrench, David; Burney, Claire; Knott, Chloe; Talbot, Georgina; Gibb, Adam; Lord, Angela; Jackson, Barry; Stern, Simon; Sutton, Taylor; Webb, Amy; Wilson, Marketa; Thomas, Nicky; Norman, Jane; Davies, Elizabeth; Lowry, Lisa; Maddox, Jamie; Phillips, Neil; Crosbie, Nicola; Flont, Marcin; Nga, Emma; Virchis, Andres; Camacho, Raisa Guerrero; Swe, Wunna; Pillai, Arvind; Rees, Clare; Bailey, James; Jones, Steve; Smith, Susan; Sharpley, Faye; Hildyard, Catherine; Mohamedbhai, Sajir; Nicholson, Toby; Moule, Simon; Chaturvedi, Anshuman; Linton, Kim
errShare
errSave
Time to progression of disease and outcomes with second-line BTK inhibitors in relapsed/refractory mantle cell lymphoma
err2023-08-11
err7
errOAAI
errVilla, Diego; Jiang, Aixiang; Visco, Carlo; Crosbie, Nicola; Mcculloch, Rory; Buege, Michael J.; Kumar, Anita; Bond, David A.; Paludo, Jonas; Maurer, Matthew J.; Thanarajasingam, Gita; Lewis, Katharine L.; Cheah, Chan Y.; Baech, Joachim; El-Galaly, Tarec C.; Kugathasan, Laveniya; Scott, David W.; Gerrie, Alina S.; Lewis, David
errShare
errSave
Efficacy of pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in Richter transformation: Results from the phase 1/2 BRUIN study
err2023-04-14
err2
PREAI
errRhodes, Joanna; Lewis, David; Ghia, Paolo; Shah, Nirav N.; Coombs, Catherine C.; Cheah, Chan Y.; Woyach, Jennifer; Lamanna, Nicole; Hoffmann, Marc S.; Ma, Shuo; Eyre, Toby A.; Munir, Talha; Patel, Manish R.; Alencar, Alvaro J.; Tam, Constantine S.; Seymour, John F.; Jurczak, Wojciech; Lech-Maranda, Ewa; Roeker, Lindsey E.; Thompson, Philip A.; Abada, Paolo B.; Wang, Chunxiao; Nair, Binoj; Liu, Hui; Tsai, Donald E.; Mato, Anthony R.; Wierda, William G.
errShare
errSave
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma
err2022-06-30
err101
errOAAI
errWang, Michael L.; Jurczak, Wojciech; Jerkeman, Mats; Trotman, Judith; Zinzani, Pier L.; Belada, David; Boccomini, Carola; Flinn, Ian W.; Giri, Pratyush; Goy, Andre; Hamlin, Paul A.; Hermine, Olivier; Hernandez-Rivas, Jose-Angel; Hong, Xiaonan; Kim, Seok Jin; Lewis, David; Mishima, Yuko; Ozcan, Muhit; Perini, Guilherme F.; Pocock, Christopher; Song, Yuqin; Spurgeon, Stephen E.; Storring, John M.; Walewski, Jan; Zhu, Jun; Qin, Rui; Henninger, Todd; Deshpande, Sanjay; Howes, Angela; Le Gouill, Steven; Dreyling, Martin
errShare
errSave
A phase 1/2 study of thiotepa-based immunochemotherapy in relapsed/refractory primary CNS lymphoma: the TIER trial
err2021-10-20
err12
errOAAI
errFox, Christopher P.; Ali, Ayesha S.; McIlroy, Graham; Thust, Steffi; Martinez-Calle, Nicolas; Jackson, Aimee E.; Hopkins, Louise M.; Thomas, Catherine M.; Kassam, Shireen; Wright, Josh; Chaganti, Sridhar; Smith, Jeffery; Chau, Ian; Culligan, Dominic; Linton, Kim M.; Collins, Graham P.; Ferreri, Andres J. M.; Lewis, David; Davies, Andrew J.; Johnson, Rod; Auer, Dorothee P.; Cwynarski, Kate
errShare
errSave
Avelumab in relapsed/refractory classical Hodgkin lymphoma: phase 1b results from the JAVELIN Hodgkins trial
err2021-09-03
err22
errOAAI
errHerrera, Alex F.; Burton, Catherine; Radford, John; Miall, Fiona; Townsend, William; Santoro, Armando; Zinzani, Pier Luigi; Lewis, David; Fowst, Camilla; Brar, Satjit; Huang, Bo; Thall, Aron; Collins, Graham P.
errShare
errSave
Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study
errLANCET
IF88.5
err2021-09-01
err213
errOAAI
errHutchings, Martin; Mous, Rogier; Clausen, Michael Roost; Johnson, Peter; Linton, Kim M.; Chamuleau, Martine E. D.; Lewis, David John; Balari, Anna Sureda; Cunningham, David; Oliveri, Roberto S.; Elliott, Brian; DeMarco, Dena; Azaryan, Ada; Chiu, Christopher; Li, Tommy; Chen, Kuo-mei; Ahmadi, Tahamtan; Lugtenburg, Pieternella J.
errShare
errSave
Subcutaneous (SC) epcoritamab induces complete responses across R/R B-cell NHL subtypes: Updated dose-escalation data
err2021-07-01
err0
errOAAI
errHutchings, Martin; Mous, Rogier; Clausen, Michael Roost; Johnson, Peter; Linton, Kim M.; Chamuleau, Martine E. D.; Lewis, David J.; Balari, Anna Sureda; Cunningham, David; Oliveri, Roberto S.; DeMarco, Dena; Elliott, Brian; Chen, Kuo-mei; Lugtenburg, Pieternella J.
errShare
errSave
Ultrastructural localization of sulfated and unsulfated keratan sulfate in normal and macular corneal dystrophy type I
err2000-03-01
err38
errOAAI
errLewis, D; Davies, Y; Nieduszynski, IA; Lawrence, F; Quantock, AJ; Bonshek, R; Fullwood, NJ
errShare
errSave